Funding for this research was provided by:
National Natural Science Foundation of China (32070767)
Received: 6 April 2022
Revised: 5 July 2022
Accepted: 7 July 2022
First Online: 25 July 2022
: WW is a co-founder and consultant for the ReKindle Therapeutics. Other authors declare no competing interests.